Investors in Alexion Pharmaceuticals Inc. (Symbol: ALXN) saw new options begin trading this week, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is ...
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We ...
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors ...
Investors in Alexion Pharmaceuticals Inc. (Symbol: ALXN) saw new options begin trading this week, for the November 20th expiration. One of the key data points that goes into the price an option buyer ...
The equity tends to heat up in the summer months Like most of the stock market, the shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have struggled in May, down nearly 10% so far. However, now ...
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) is honored to support Rare Disease Day 2019 with the launch of #RallyforRare, a global social media campaign that aims to raise ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) said today that its Board of Directors and Elliott have agreed to work collaboratively to promptly identify a new member ...
NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) ...
Alexion Pharmaceuticals Inc (NASDAQ:ALXN) is climbing higher today, up 3.7% at $119.50 at last check, after word that the company plans to raise its 2020 full-year guidance. On Oct. 28, the estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results